Single-day praziquantel versus 1-week albendazole for neurocysticercosis

被引：38

作者：

Del Brutto, OH ^{[1
]}

Campos, X ^{[1
]}

Sánchez, J ^{[1
]}

Mosquera, A ^{[1
]}

机构：

[1] Luis Vernaza Hosp, Dept Neurol, Guayaquil, Ecuador

来源：

NEUROLOGY | 1999年 / 52卷 / 05期

关键词：

D O I：

10.1212/WNL.52.5.1079

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The efficacy of albendazole (15 mg/kg/d for 1 week) was compared with praziquantel (100 mg/kg in three divided doses at 2-hour intervals) for therapy of parenchymal brain cysticercosis. Ten patients were treated with albendazole and 10 patients with praziquantel. Although the total number of cysts was significantly reduced from 64 to 7 in patients treated with albendazole and from 59 to 24 in those treated with praziquantel, the number of patients improving with albendazole was not significantly different from those treated with praziquantel.

引用

收藏

页码：1079 / 1081

页数：3

相关论文

共 8 条

[1] HIGH-DOSE PRAZIQUANTEL FOR NEUROCYSTICERCOSIS - EFFICACY AND TOLERABILITY [J].

BITTENCOURT, PRM ;

GRACIA, CM ;

GORZ, AM ;

MAZER, S ;

OLIVEIRA, TV .

EUROPEAN NEUROLOGY, 1990, 30 (04) :229-234

[2] Single-day praziquantel therapy for neurocysticercosis [J].

Corona, T ;

Lugo, R ;

Medina, R ;

Sotelo, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (02) :125-125

[3] ALBENDAZOLE VERSUS PRAZIQUANTEL IN THE TREATMENT OF CEREBRAL CYSTICERCOSIS - CLINICAL-EVALUATION [J].

CRUZ, M ;

CRUZ, I ;

HORTON, J .

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1991, 85 (02) :244-247

[4] MEDICAL-TREATMENT OF CYSTICERCOSIS - EFFECTIVE [J].

DELBRUTTO, OH .

ARCHIVES OF NEUROLOGY, 1995, 52 (01) :102-104

[5] Albendazole therapy for neurocysticercosis: A prospective double-blind trial comparing 7 versus 14 days of treatment [J].

Garcia, HH ;

Gilman, RH ;

Horton, J ;

Martinez, M ;

Herrera, G ;

Altamirano, J ;

Cuba, JM ;

RiosSaavedra, N ;

Verastegui, M ;

Boero, J ;

Gonzalez, AE ;

Alvarado, M ;

Orrillo, E ;

Trelles, L ;

Escalante, S ;

Palomino, L ;

Alban, G ;

Estrada, H ;

Velarde, M ;

Garate, E ;

Martinez, H ;

Soto, M ;

Catacora, M ;

Guerron, A ;

Romani, C ;

Diaz, F ;

Torres, MP ;

Gavidia, C ;

Barron, E ;

Falcon, N ;

Lopez, MT ;

Tsang, VCW ;

Pilcher, JB ;

Rivara, A ;

Terashima, A ;

Campos, P ;

Cabrera, J ;

Rocca, U .

NEUROLOGY, 1997, 48 (05) :1421-1427

[6] COMPARISON OF THERAPEUTIC REGIMEN OF ANTICYSTICERCAL DRUGS FOR PARENCHYMAL BRAIN CYSTICERCOSIS [J].

SOTELO, J ;

DELBRUTTO, OH ;

PENAGOS, P ;

ESCOBEDO, F ;

TORRES, B ;

RODRIGUEZCARBAJAL, J ;

RUBIODONNADIEU, F .

JOURNAL OF NEUROLOGY, 1990, 237 (02) :69-72

[7] THERAPY OF PARENCHYMAL BRAIN CYSTICERCOSIS WITH PRAZIQUANTEL [J].

SOTELO, J ;

ESCOBEDO, F ;

RODRIGUEZCARBAJAL, J ;

TORRES, B ;

RUBIODONNADIEU, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (16) :1001-1007

[8] THERAPY FOR NEUROCYSTICERCOSIS - COMPARISON BETWEEN ALBENDAZOLE AND PRAZIQUANTEL [J].

TAKAYANAGUI, OM ;

JARDIM, E .

ARCHIVES OF NEUROLOGY, 1992, 49 (03) :290-294